Biogen Inc. (BIIB) vs Medline Inc. (MDLN)

BIIB leads on 9 of 11 compared metrics.

A side-by-side comparison of Biogen Inc. and Medline Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 13, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).

Total return — BIIB vs MDLN

growth of $100 · last 1y
BIIB +16.2%MDLN -10.7%BIIB compounded faster
8090100110120Start $1002026$116$89
BIIB MDLN

BIIB vs MDLN: by the numbers

  • MDLN is the larger company ($30.96B vs $29.53B market cap).
  • BIIB trades at the lower earnings multiple (21.42 vs 30.26 P/E).
  • BIIB converts more revenue to profit (13.92% vs 3.31% net margin).

Which is better, BIIB or MDLN?

Metric tally: BIIB 9 · MDLN 2

It depends on what you're optimizing for:

ValueBIIB(lower P/E)
QualityBIIB(higher ROIC)

Valuation

MetricBIIBMDLN
P/E ratio21.4230.26
Forward P/E12.2322.08
P/S ratio3.011.04
P/B ratio1.592.68
EV / EBITDA12.1614.84
FCF yield8.83%5.05%

Profitability

MetricBIIBMDLN
Gross margin69.77%24.04%
Operating margin15.65%7.04%
Net margin13.92%3.31%
ROE7.36%8.55%
ROIC6.62%5.69%

Growth (annualized)

MetricBIIBMDLN
Revenue CAGR (5Y)-4.80%
EPS CAGR (5Y)-18.67%
FCF CAGR (5Y)-3.59%
Total return CAGR (5Y)-12.79%

Frequently asked

Which is better, BIIB or MDLN?
It depends on your goal. value: BIIB (lower P/E); quality: BIIB (higher ROIC). Across all compared metrics, BIIB leads 9 to 2.
Is BIIB or MDLN cheaper?
On trailing earnings, BIIB is cheaper: BIIB trades at a 21.42 P/E and MDLN at 30.26.
Is BIIB or MDLN more profitable?
BIIB runs the higher net margin — BIIB at 13.92% versus MDLN at 3.31%.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 13, 2026.